Related references
Note: Only part of the references are listed.Long-Term Outcomes in the Second-Line Treatment of Chronic Myeloid Leukemia A Review of Tyrosine Kinase Inhibitors
Elias Jabbour et al.
CANCER (2011)
Human epidermal growth factor receptor-2-positive breast cancer: current management of early, advanced, and recurrent disease
Rena Callahan et al.
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2011)
CA125 surveillance increases optimal resectability at secondary cytoreductive surgery for recurrent epithelial ovarian cancer
Nicole D. Fleming et al.
GYNECOLOGIC ONCOLOGY (2011)
The insulin-like growth factor 1 pathway is a potential therapeutic target for low-grade serous ovarian carcinoma
Erin R. King et al.
GYNECOLOGIC ONCOLOGY (2011)
Imatinib as adjuvant therapy for gastrointestinal stromal tumors: a systematic review
Munira Essat et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Subtype-specific mutation of PPP2R1A in endometrial and ovarian carcinomas
Melissa K. McConechy et al.
JOURNAL OF PATHOLOGY (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
RNA interference in the clinic: challenges and future directions
Chad V. Pecot et al.
NATURE REVIEWS CANCER (2011)
BRAF Mutation Is Rare in Advanced-Stage Low-Grade Ovarian Serous Carcinomas
Kwong-Kwok Wong et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
Robert J. Kurman et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
CA 125 and the Detection of Recurrent Ovarian Cancer
Robert C. Bast
CANCER (2010)
SIK2 Is a Centrosome Kinase Required for Bipolar Mitotic Spindle Formation that Provides a Potential Target for Therapy in Ovarian Cancer
Ahmed Ashour Ahmed et al.
CANCER CELL (2010)
Tumor Antigen Acrosin Binding Protein Normalizes Mitotic Spindle Function to Promote Cancer Cell Proliferation
Angelique W. Whitehurst et al.
CANCER RESEARCH (2010)
Personalized medicine for non-small-cell lung cancer
Tony S. Mok et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2010)
Targeted trials in ovarian cancer
Jonathan A. Ledermann et al.
GYNECOLOGIC ONCOLOGY (2010)
Personalizing Therapy for Ovarian Cancer: BRCAness and Beyond
Robert C. Bast et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Development of a Multimarker Assay for Early Detection of Ovarian Cancer
Zoya Yurkovetsky et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial
Gordon J. S. Rustin et al.
LANCET (2010)
Researchers find a new cancer gene and a possible link between ovarian cancer and endometriosis
[Anonymous]
WOMENS HEALTH (2010)
ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas
Kimberly C. Wiegand et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Cancer Statistics, 2009
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
Therapeutic Targeting of ATP7B in Ovarian Carcinoma
Lingegowda S. Mangala et al.
CLINICAL CANCER RESEARCH (2009)
Evaluation of New Platinum-Based Treatment Regimens in Advanced-Stage Ovarian Cancer: A Phase III Trial of the Gynecologic Cancer InterGroup
Michael A. Bookman et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
Usha Menon et al.
LANCET ONCOLOGY (2009)
The biology of ovarian cancer: new opportunities for translation
Robert C. Bast et al.
NATURE REVIEWS CANCER (2009)
Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome
Richard W. Tothill et al.
CLINICAL CANCER RESEARCH (2008)
A meta-analysis of the efficacy of intraperitoneal cisplatin for the front-line treatment of ovarian cancer
L. M. Hess et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2007)
Mdm2 inhibitor Nutlin-3a induces p53-mediated apoptosis by transcription-dependent and transcription-independent mechanisms and may overcome Atm-mediated resistance to fludarabine in chronic lymphocytic leukemia
Kensuke Kojima et al.
BLOOD (2006)
Intraperitoneal cisplatin and paclitaxel in ovarian cancer
DK Armstrong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Risk of epithelial ovarian cancer recurrence in patients with rising serum CA-125 levels within the normal range
A Santillan et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Potential markers that complement expression of CA125 in epithelial ovarian cancer
DG Rosen et al.
GYNECOLOGIC ONCOLOGY (2005)
Lineage infidelity of epithelial ovarian cancers is controlled by HOX genes that specify regional identity in the reproductive tract
WJ Cheng et al.
NATURE MEDICINE (2005)
Clinical implications of a rising serum CA-125 within the normal range in patients with epithelial ovarian cancer: a preliminary investigation
JL Wilder et al.
GYNECOLOGIC ONCOLOGY (2003)
Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene
XP Qu et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Share Paper
